Pulse Biosciences Faces Investor Skepticism Amidst Technology Scrutiny
Pulse Biosciences Inc. faces mounting criticism and skepticism over the commercial viability and efficacy of its nano-pulse technology, which has led to a significant drop in its stock price and a call for transparency and tangible results.
3 minutes to read